Knight Therapeutics Inc

Insider Reports History

Location
Montreal, Quebec, Canada
Signature
/s/ Samira Sakhia
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Knight Therapeutics Inc:

Company Role Class Num Shares Value Price $ Report Date Ownership
Synergy CHC Corp. 10%+ Owner Common Stock, par value $0.00001 per share 1,482,844 $6,020,347 $4.06 22 Oct 2024 Held through Knight Therapeutics International SA, a subsidiary of Knight Therapeutics Inc.
60 DEGREES PHARMACEUTICALS, INC. Former 10% Owner Common Stock, $0.0001 par value per share ("Common Shares") 1,153,897 $5,475,241 $4.74 28 Jul 2023 By Knight Therapeutics International S.A.
Synergy CHC Corp. 10%+ Owner Pre-Funded Common Stock Purchase Warrant 428,570 11 Jun 2025 Indirect
60 DEGREES PHARMACEUTICALS, INC. Former 10% Owner Series A Non-Voting Convertible Preferred Stock 78,803 28 Jul 2023 By Knight Therapeutics International S.A.

Insider Reports Filed by Knight Therapeutics Inc

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNYR Synergy CHC Corp. 11 Jun 2025 1 $0 4 10%+ Owner 13 Jun 2025, 16:05
SNYR Synergy CHC Corp. 22 Oct 2024 0 $0 3 10%+ Owner 22 Oct 2024, 20:30
SXTP 60 DEGREES PHARMACEUTICALS, INC. 28 Jul 2023 2 +$216,182 4 Former 10% Owner 03 Apr 2024, 18:00
SXTP 60 DEGREES PHARMACEUTICALS, INC. 11 Jul 2023 0 $0 3 10%+ Owner 18 Dec 2023, 09:23